Join to access to all OVN content. Join for Free

Results for 'RB'

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Partner Avatar Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology

Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8th • 20 mins listen

Redefining Ovarian Cancer Care with Biomarkers
Partner Avatar Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers

Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.

Sep 7th • 14 mins listen

New ‘Social’ Technology to Help Identify KEY Trends for Medical Affairs
Partner Avatar MSL Talk: Tom Caravela, Tim Bialekki , Alec McCarthy
New ‘Social’ Technology to Help Identify KEY Trends for Medical Affairs

Google Trends, COVID-19 research, medical affairs, pharmaceutical analysis, social arbitrage

In this episode, Tom Caravela is joined by Tim Bialekki and Alec McCarthy to explore the intersection of Google Trends and the MSL role. The discussion delves into how Google Trends can be utilized in COVID-19 research and its implications for medical affairs and pharmaceutical analysis. The sp…

Jul 20th • 35 mins listen

Filler Words Fix the Problem You Didn't Know You Had
Partner Avatar MSL Talk: Tom Caravela
Filler Words Fix the Problem You Didn't Know You Had

filler words, communication skills, professional presence, audience engagement, verbal fillers

In this episode, Tom Caravela delves into the significance of eliminating filler words in professional as well as personal communication. He highlights the impact of these verbal fillers on perceived competence and interview performance, supported by revealing statistics. Tom explores the demographi…

Dec 18th • 26 mins listen

At the Crossroads of Cancer and Metabolism
Partner Avatar Monty Pal
At the Crossroads of Cancer and Metabolism

City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism

Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.

Jul 7th • 37 mins listen

How Cross-Functional Teams Reshape Cancer Care
OVN Avatar Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care

Jay Fine, Preclinical Research, Early Stage

In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.

Feb 17th • 23 mins listen

Emotional Intelligence and why it is important for MSLs with Jessica Freund
Partner Avatar MSL Talk: Tom Caravela, Jessica Freund
Emotional Intelligence and why it is important for MSLs with Jessica Freund

Emotional Intelligence for MSLs, Medical Science Liaison career, Networking in pharmaceutical industry, Evaluating emotional intelligence, MSL interview strategies

In this episode, Jessica Freund from Biogen shares her journey into the pharmaceutical industry, highlighting her transition from Sanofi and her current role. The discussion delves into the significance of emotional intelligence for Medical Science Liaisons (MSLs), exploring its definition, tea…

Apr 14th • 30 mins listen

Paying it Forward (And Back)… Finding Medical Affairs Success as an Industry MD
Partner Avatar MSL Talk: Tom Caravela, Mena Boules
Paying it Forward (And Back)… Finding Medical Affairs Success as an Industry MD

Medical Affairs, Pharmaceutical Industry, Mentorship Importance, Career Transition, MSL Career Advice

In this episode, Mena Boules shares his journey from a clinical background to a successful career in the pharmaceutical industry. He emphasizes the critical role mentorship played in his transition and how he navigated the learning curve in his new role. Mena discusses the dynamic landscape of …

Feb 14th • 29 mins listen

Career Currency: The Key to Your Success
Partner Avatar MSL Talk: Tom Caravela, Rachel Couchenour
Career Currency: The Key to Your Success

network building, career currency, MSL networking, internal relationships, job search strategies

In this week’s episode, Rachel Couchenour, Vice President Global Medical Affairs at Travere Therapeutics, discusses the importance of building your internal and external network. Learn more about… 👉 What is career currency👉 Why it is so important for MSLs to build a strong i…

Jul 9th • 33 mins listen

Advancing Clinical Trial Equity
OVN Avatar Cancer Buzz Podcast
Advancing Clinical Trial Equity

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…

Jun 25th • 8 mins listen

The Practical Side of Clinical Trials
OVN Avatar The Oncology Nursing Podcast
The Practical Side of Clinical Trials

ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…

Sep 18th • 39 mins listen

Breaking Down Checkpoint Inhibitors
OVN Avatar The Oncology Nursing Podcast
Breaking Down Checkpoint Inhibitors

ONS member Virginia Bayer, BSN, RN, CCRP, research nurse supervisor at MD Anderson Cancer Center, joins ONS’s Barbara Lubejko, MS, RN, to discuss checkpoint inhibitors, their impact on patient care, what oncology nurses need to know about immunotherapies, and much more.

Mar 14th • 51 mins listen

 CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
OVN Avatar The Oncology Nursing Podcast
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation

“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…

May 24th • 40 mins listen

Address Knowledge Gaps in Evidence-Based Precision Medicine Care
OVN Avatar The Oncology Nursing Podcast
Address Knowledge Gaps in Evidence-Based Precision Medicine Care

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss knowledge gaps in clinical practic…

Mar 29th • 40 mins listen

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…

Mar 30th • 47 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...